Long-term effect of intermittent cyclical etidronate on microarchitecture and quality of trabecular bone in an elderly woman with severe osteoporosis

Journal of Bone and Mineral Metabolism

Volumn 22, Issue 2, 2004, Pages 153-158

  Nakatsuka, Kiyoshi ^a   Miki, Takami ^a   Naka, Hiroshi ^a   Inaba, Masaaki ^a   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone histomorphometry; Etidronate; Microarchitecture; Osteoporosis; Safety

Indexed keywords

ETIDRONIC ACID;

AGED; ARTICLE; BONE BIOPSY; BONE REMODELING; CASE REPORT; DISEASE SEVERITY; DRUG INTERMITTENT THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRAGILITY FRACTURE; HUMAN; LONG TERM CARE; MORPHOMETRICS; OSTEOPOROSIS; PRIORITY JOURNAL; TRABECULAR BONE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BIOPSY; BONE DENSITY; DRUG ADMINISTRATION SCHEDULE; ETIDRONIC ACID; FEMALE; HUMANS; ILIUM; JAPAN; LUMBAR VERTEBRAE; OSTEOPOROSIS;

EID: 1642545512     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-003-0464-0     Document Type: Article

References (30)

1. Consensus development conference (1993) Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646-650
2. Meunier PJ, Delmas PD, Eastell R, McClung MR, Papapoulos S, Rizzoli R, Seeman E, Wasnich RD (1999) For the International Committee for Osteoporosis Clinical Guidelines. Diagnosis and management of osteoporosis in postmenopausal women: clinical Guidelines. Clin Ther 21:1025-1044
3. Fleisch H (1997) Commercially available bisphosphonates. In: Fleisch H (ed) Bisphosphonates in Bone Disease: From the Laboratory to the Patient, 3rd edn. Parthenon, New York, pp 164-180
4. Lauffenburger T, Olah AJ, Dambacher MA, Guncaga J, Lentner C, Haas HG (1977) Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's disease. Metabolism 26:589-606
5. Thomas T, Lafage MH, Alexandre C (1995) Atypical osteomalacia after 2 year etidronate cyclic administration in osteoporosis. J Rheumatol 22:2183-2185
6. Wimalawansa SJ (1995) Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study. Am J Med 99:36-42
7. Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH (1990) Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322:1265-1271
8. Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson GC III, Yanover MJ, Mysiw J, Kohse L, Rao MB, Steiger P, Richmond B, Chesnut CH III (1990) Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323:73-79
9. Fujita T, Orimo H, Inoue T, Kaneda K, Sakurai M, Morita R, Morii H, Yamamoto K, Sugioka Y, Inoue A, Hoshino Y, Kawaguchi H, Yamamoto I, Fukase M, Takaoka K (1993) Double-blind multicenter comparative study with alfacalcidol of etidronate disodium (EHDP) in involutional osteoporosis (in Japanese). Clin Eval 21:261-302
10. Harris ST, Watts NB, Jackson RD, Genant HK, Wasnich RD, Ross P, Miller PD, Licata AA, Chesnut CH III (1993) Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med 95:557-567
11. Montessori ML, Scheele WH, Netelenbos JC, Kerkhoff JF, Bakker K (1997) The use of etidronate and calcium versus calcium alone in the treatment of postmenopausal osteopenia: results of three years of treatment. Osteoporos Int 7:52-58
12. Storm T, Kollerup G, Thamsborg G, Genant HK, Sorensen OH (1996) Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis. J Rheumatol 23:1560-1564
13. Miller PD, Watts NB, Licata AA, Harris ST, Genant HK, Wasnich RD, Ross PD, Jackson RD, Hoseyni MS, Schoenfeld SL, Valent DJ, Chesnut CH III (1997) Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment. Am J Med 103:468-476
14. Fujita T, Inoue T, Morii H, Norimatsu H, Orimo H, Takahashi HE, Yamamoto K, Fukunaga M (1999) Effect of an intermittent weekly doses of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose levels. Osteoporosis Int 9:296-306
15. Recker RR, Kimmel DB, Parfitt AM, Davies KM, Keshawarz N, Hinders S (1988) Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res 3:133-144
16. Mellish RWE, Ferguson-Pell MW, Cochran GVB, Lindsay R, Dempster DW (1991) A new manual method for assessing two-dimensional cancellous bone structure: comparison between iliac crest and lumbar vertebra. J Bone Miner Res 6:689-696
17. Steiniche T, Hasling C, Charles P, Eriksen EF, Melsen F, Mosekilde L (1991) The effects of etidronate on trabecular bone remodeling in postmenopausal spine osteoporosis: a randomized study comparing intermittent treatment and ADFR regime. Bone 12:155-165
18. Storm T, Steinche T, Thamsborg RW, Melsen F (1993) Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis. J Bone Miner Res 8:199-208
19. Frost HM (1981) Coherence treatment of osteoporosis. Orthop Clin N Am 12:649-669
20. Hodsman AB (1989) Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study. Bone Miner 5:201-212
21. Ott SM, Woodson GC, Huffer WE, Miller PD, Watts NB (1994) Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 78:968-972
22. Melsen F, Steinche T (1989) Bone histomorphometry. Osteoporos Int 3:98-99
23. Lacy ME, Bevan JA, Boyce RW, Geddes AD (1994) Antiresorptive drugs and trabecular bone turnover: validation and testing of a computer model. Calcif Tissue Int 54:179-185
24. Fujita T, Orimo H, Inoue T (1994) A dose finding study on osteoporosis of etidronate disodium (EHDP) (in Japanese). Clin Rep 28:447-486
25. Thomas T, Barou O, Vico L, Alexandre C, Lafage-Proust MH (1999) Recurrence of vertebral fracture with cyclic etidronate therapy in osteoporosis: histomorphometry and X-ray microanalysis evaluation. J Bone Miner Res 14:198-205
26. Ross PD, Davis JW, Epstein RS, Wasnich RD (1991) Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114:919-923
27. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelefert L, Shane E, Muller R, Bilezilian J, Lindsay R (2001) Effects of daily treatment with parathyroid hormone on microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16:1846-1853
28. Miki T, Nakatsuka K, Kitatani K, Kawakami H, Naka H, Nishizawa Y, Morii H (1998) Efficacy of bone resorption inhibitors predicted by deoxypyridinoline in postmenopausal women. Osteoporos Int 8 (suppl 3):77
29. Nuzzo S, Lafage-Proust MH, Martin-Badosa E, Boivin G, Thomas T, Alexandre C, Peyrin F (2002) Synchrotron radiation microtomography allows the analysis of three dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens: effects of etidronate treatment. J Bone Miner Res 17:1372-1382
30. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Munier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols and units. J Bone Miner Res 2:595-610